top of page

Free Biopharma Daily Stock Updates - 07/13/21

  • Writer: BPIQ
    BPIQ
  • Jul 13, 2021
  • 2 min read

$XBI $129.63 -1.7%

Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days free, no credit card required. Check it out here!


Pipeline Updates

$SCPH +7.3% scPharmaceuticals Inc. Announces Positive Top-Line Results from FREEDOM-HF Study. source


$JAZZ -1.2% Jazz Pharmaceuticals Announces Rylaze™ (asparaginase erwinia chrysanthemi (recombinant)-rywn) Investor Webcast on July 20, 2021. source


$HEPA -15.3% Hepion Pharmaceuticals Announces Positive Topline Data from Phase 2a ‘AMBITION’ NASH Trial; All Primary Endpoints Achieved. source


$RDHL -2.1% RedHill Biopharma's Movantik® Added as Unrestricted Preferred Brand To A Major National Commercial Formulary Serving over 30 Million Americans. source


$GLTO -3.8% Galecto Resumes Recruitment in Phase 2b Global GALACTIC-1 Trial of GB0139 for Idiopathic Pulmonary Fibrosis. source


$MBRX -0.3% Moleculin Receives Approval to Extend Dose Escalation in Phase 1/2 European Clinical Trial Evaluating Annamycin for the Treatment of Acute Myeloid Leukemia. source


$TFFP +0.4% TFF Pharmaceuticals Announces Completion of Enrollment and Preliminary Data from its Phase 1 Clinical Trial of Tacrolimus Inhalation Powder. source


$SBBP -2.4% Strongbridge Biopharma plc Announces Publication of Long-term Efficacy and Safety Results for KEVEYIS® (dichlorphenamide) for the Treatment of Primary Periodic Paralysis in Muscle & Nerve. source


$GNCA -1.0% Genocea Doses First Patient in Phase 1/2a TiTAN Clinical Trial for GEN-011 Neoantigen-Targeted T cell Therapy. source


$LVTX -1.1% LAVA Therapeutics Announces Treatment of First Patient in Phase 1/2a Clinical Trial of LAVA-051 for Multiple Hematological Malignancies. source


$HCM +1.7% First Commercial Sale of ORPATHYS® in China Triggering a US$25 million Milestone Payment from AstraZeneca. source


$PLXP +27.2% PLx Pharma Inc.’s VAZALORE to Launch in over 4,500 Walmart Stores Nationwide in August. source


$IKNA -16.5% Ikena Oncology to Participate in Targeted Oncology Panel at the William Blair Biotech Focus Conference 2021 on July 15. source


$INMB +12.7% INmune Bio, Inc. Announces First Patient Treated with NK cell priming “pseudokine” INKmune in High-Risk Myelodysplastic Syndrome (MDS). source



Financial Updates

$CLRB -3.5% Cellectar Announces Expansion of Ongoing Collaboration Agreement with IntoCell Inc. source


$PCRX -2.1% Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021. source


$KALV -3.3% KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results. source


$IONS -2.5% Ionis enters exclusive licensing agreement with Bicycle Therapeutics aimed at further advancing LICA technology. source


$BCYC +4.1% Bicycle Therapeutics Enters Exclusive License and Collaboration Agreement with Ionis to Develop Targeted Oligonucleotide Therapeutics. source


$ISEE +4.6% IVERIC bio, Inc. Announces Pricing of $100 Million Public Offering of Common Stock. source

Posted by FS

 
 
 

Comments

bottom of page